Forum Discussion
Two steps forward, one step back – news on access to CDKs in second line treatment
Hello everyone,
BCNA has an update on access to CDKs as
second line treatment. Pfizer have this week advised BCNA about a new capped access
program for the CDK inhibitor palbociclib (lbrance) wh...
756Views
Sign in to react to this post
@Patti J
Goodness it's all about timing
Excellent to read
Best wishes
Take care
Goodness it's all about timing
Excellent to read
Best wishes
Take care